Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

The Nutrient Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase

Laura F. Mendez, Hellen Nguyen, Jenny Nguyen, Alexander Himstead, Melinda R. Lemm, Elena S. Heide, Robyn M. Scherber, MDMPH, Aditi Choudhry, MD, Chelsea O. McKinney, Ruben A. Mesa, MD, Lari Wenzel, Andrew Odegaard, Angela G. Fleischman, MD PhD

Blood (2019) 134 (Supplement_1): 5380.

https://doi.org/10.1182/blood-2019-130851

Published: 2019

Journal Articles

Persistent Leukocytosis in Polycythemia Vera Is Associated with Disease Evolution but Not Thrombosis: An Analysis from a 520-Patient Retrospective Multi-Center Database

Blood (2019) 134 (Supplement_1): 2949.

https://doi.org/10.1182/blood-2019-121533

Published: 2019

Journal Articles

Single-Cell RNA-Seq to Assess Differential Responses to Tnfα in Human Hematopoietic Stem and Progenitor Cells in Myeloproliferative Neoplasm

Brianna Craver, MS, Quy Nguyen, Gajalakshmi Ramanathan, PhD, Angela G. Fleischman, MD PhD

Blood (2019) 134 (Supplement_1): 2518.

https://doi.org/10.1182/blood-2019-123480

Published: 2019

Journal Articles

JAK2V617F Hematopoietic Stem and Progenitors Are More Resistant to Chronic Blockage of IL-10 Signaling in a Murine Model of Myeloproliferative Neoplasms

Hew Yeng Lai, PhD, Tiffany Trieu, Tiffany Han, Stefan Brooks, Brianna Craver, MS, Gajalakshmi Ramanathan, PhD, Angela G. Fleischman, MD PhD

Blood (2019) 134 (Supplement_1): 4206.

https://doi.org/10.1182/blood-2019-131166

Published: 2019

Journal Articles

Statins Enhance the Efficacy of BH3 Mimetics in Multiple Myeloma

Dennis Juarez, BS, David Alexander Fruman, PhD, Angela G. Fleischman, MD PhD, Elizabeth Brem, MD, Grace Diep, Undergraduate, Falisha Nguyen, Undergraduate

Blood (2018) 132 (Supplement 1): 1989.

https://doi.org/10.1182/blood-2018-99-120205

Published: 2018

Journal Articles

Psychostimulant Use Among Myeloproloferative Neoplasm Patients

Robyn M. Scherber, MD, Blake T. Langlais, Heidi Elizabeth Kosiorek, MS, Amylou Dueck, PhD, Holly Geyer, MD, Zhenya Senyak, Archie McCallister, MD, Mary Cotter, MA, Barbara VanHusen, Jeanne Palmer, MD, Leslie Padrnos, MD, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Angela G. Fleischman, MD PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 5657.

https://doi.org/10.1182/blood.V130.Suppl_1.5657.5657

Published: 2017

Journal Articles

Needs and Preferences Regarding Nutrition and Supplement Use Among Individuals with Myeloproliferative Neoplasms: A Focus Group Study

Robyn M. Scherber, MD, Sarah Morse, MS, Anais Leproux, PhD, Brianna M Craver, MS, Hew Yeng Lai, Holly Geyer, MD, Amylou C. Dueck, PhD, Jeanne Palmer, MD, Leslie Padrnos, MD, Ruben A Mesa, MD, Angela G. Fleischman, MD PhD

Blood (2017) 130 (Supplement 1): 5669.

https://doi.org/10.1182/blood.V130.Suppl_1.5669.5669

Published: 2017

Journal Articles

Nutrition and Supplement Use Characteristics in the Myeloproliferative Neoplasms: Results from the Nutrient Survey

Robyn M. Scherber, MD, Blake T. Langlais, Holly Geyer, MD, Amylou Dueck, PhD, Heidi Kosoriek, MS, Carol Johnston, PhD RD, Leslie Padrnos, MD, Jeanne Palmer, MD, Angela G. Fleischman, MD PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 2193.

https://doi.org/10.1182/blood.V130.Suppl_1.2193.2193

Published: 2017

Journal Articles

Overexpression of Calreticulin Impairs Self-Renewal Capacity of Hematopoietic Stem Cells

Stefan Brooks, Sarah Morse, MS, Brianna Craver, MS, Hew Yeng Lai, Thanh Kim Nguyen, PhD, Daniel Kim, Angela G. Fleischman, MD PhD, Prasanthi Tata, Nilamani Jena, PhD, Zhong-Ying Liu, Richard A. Van Etten, MD PhD

Blood (2017) 130 (Supplement 1): 4937.

https://doi.org/10.1182/blood.V130.Suppl_1.4937.4937

Published: 2017

Journal Articles

JAK2 V617F Hematopoietic Stem Cells Exhibit a Blunted Response to Acute Inflammation

Brianna Craver, MS, Hew Yeng Lai, Sarah Morse, MS, Stefan Brooks, Daniel Kim, Angela G. Fleischman, MD PhD

Blood (2017) 130 (Supplement 1): 4211.

https://doi.org/10.1182/blood.V130.Suppl_1.4211.4211

Published: 2017

Journal Articles

The MEK/ERK Inhibitor Trametinib Reduces Fibrosis in a Transduction-Transplantation Model of Mutated Calreticulin

Thanh Kim Nguyen, PhD, Prasanthi Tata, Stefan Brooks, BA, Nilamani Jena, PhD, Sarah J Morse, MS, BS, Zhong-ying Liu, Hew Yeng Lai, BS, Sherif Rezk, MD, Richard A. Van Etten, MD PhD, Angela G Fleischman, MD PhD

Blood (2016) 128 (22): 635.

https://doi.org/10.1182/blood.V128.22.635.635

Published: 2016

Journal Articles

Exaggerated Response To Toll-Like Receptor Agonist Contributes To Excessive TNF Production In Myeloproliferative Neoplasm

Angela G. Fleischman, MD, PhD, Samuel B Luty, BS, Michael R Garbati, PhD, J Blair Edmiston, BS, Lacey R Royer, Dorian H LaTocha, BS, Grover C. Bagby, M.D., Brian J. Druker

Blood (2013) 122 (21): 4097.

https://doi.org/10.1182/blood.V122.21.4097.4097

Published: 2013

Journal Articles

The CSF3R T618I Mutation Found In Chronic Neutrophilic Leukemia Removes An O-Linked Glycosylation Site and Increases Receptor Dimerization

Blood (2013) 122 (21): 270.

https://doi.org/10.1182/blood.V122.21.270.270

Published: 2013

Journal Articles

CSF3R T618I Mouse Bone Marrow Transplant Model Of Neutrophilic Leukemia

Julia E Maxson, PhD, Angela G. Fleischman, MD, PhD, Samuel B Luty, BS, Lacey R Royer, Anupriya Agarwal, Marc M. Loriaux, Brian J. Druker, Jeffrey W. Tyner

Blood (2013) 122 (21): 223.

https://doi.org/10.1182/blood.V122.21.223.223

Published: 2013

Journal Articles

TYK2-STAT1 Pathway Positively Regulates BCL2 Gene Expression in T-Cell Acute Lymphoblastic Leukemia

Blood (2012) 120 (21): 1470.

https://doi.org/10.1182/blood.V120.21.1470.1470

Published: 2012

Journal Articles

A Truncation Mutant of CSF3R, Identified As a Novel Driver in De Novo Myeloid Leukemia, Signals Through TNK2, and Is Responsive to Dasatinib.

Julia E Maxson, PhD, Jason Gotlib, Angela G. Fleischman, MD, PhD, Christopher A. Eide, Daniel Bottomly, MS, Beth Wilmot, PhD, MS, Shannon McWeeney, PhD, Cristina Tognon, PhD, Marc M Loriaux, MD, PhD, Brian J. Druker, Jeffrey W Tyner, PhD

Blood (2012) 120 (21): 2412.

https://doi.org/10.1182/blood.V120.21.2412.2412

Published: 2012

Journal Articles

Mutationally Activated TYK2 From T-ALL Specimens Exhibits Tranformative Capacity in Cell Lines and Primary Cell Models and T-Lineage Expansion in Mice

Angela G. Fleischman, MD, PhD, Takaomi Sanda, MD, PhD, Alejandro Gutierrez, MD, Samuel B Luty, Stephanie G Willis, A. Thomas Look, M.D., Brian J. Druker, Jeffrey W Tyner, PhD

Blood (2011) 118 (21): 74.

https://doi.org/10.1182/blood.V118.21.74.74

Published: 2011

Journal Articles

Jak2 V617F Induced TNF Resistance as a Mechanism of Clonal Expansion In Myeloproliferative Neoplasm

Angela G. Fleischman, MD, PhD, Karl J. Aichberger, MD, PhD, Curtis L Petersen, Shirin Doratotaj, MD, Thomas G Bumm, MD, Heike L. Pahl, PhD, Brian J Druker, MD, Michael W Deininger, MD, PhD

Blood (2010) 116 (21): 795.

https://doi.org/10.1182/blood.V116.21.795.795

Published: 2010

Journal Articles

Effects of Plerixafor (AMD3100) In Combination with Tyrosine Kinase Inhibition In a Murine Model of CML.

Anupriya Agarwal, PhD, Angela G. Fleischman, MD, PhD, Curtis L Petersen, Marc M Loriaux, MD, PhD, Randy Woltjer, Brian J Druker, MD, Michael W Deininger, MD, PhD

Blood (2010) 116 (21): 3389.

https://doi.org/10.1182/blood.V116.21.3389.3389

Published: 2010

Journal Articles

Tumor Necrosis Factor-Alpha (TNF) Expression Is Elevated in Myelo-Proliferative Neoplasms (MPN) and Modulated by Inhibition of JAK2 V617F.

Karl J. Aichberger, MD, PhD, Angela G. Fleischman, MD, PhD, Shirin Doratotaj, MD, Thomas G.P. Bumm, MD, Richard T. Silver, MD, Thomas G. Deloughery, MD, Heike L. Pahl, PhD, Brian J. Druker, MD, Christopher J. Burns, Michael Deininger, MD, PhD

Blood (2009) 114 (22): 2917.

https://doi.org/10.1182/blood.V114.22.2917.2917

Published: 2009

NARROW

The Nutrient Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase

Persistent Leukocytosis in Polycythemia Vera Is Associated with Disease Evolution but Not Thrombosis: An Analysis from a 520-Patient Retrospective Multi-Center Database

Single-Cell RNA-Seq to Assess Differential Responses to Tnfα in Human Hematopoietic Stem and Progenitor Cells in Myeloproliferative Neoplasm

JAK2V617F Hematopoietic Stem and Progenitors Are More Resistant to Chronic Blockage of IL-10 Signaling in a Murine Model of Myeloproliferative Neoplasms

Statins Enhance the Efficacy of BH3 Mimetics in Multiple Myeloma

Psychostimulant Use Among Myeloproloferative Neoplasm Patients

Needs and Preferences Regarding Nutrition and Supplement Use Among Individuals with Myeloproliferative Neoplasms: A Focus Group Study

Nutrition and Supplement Use Characteristics in the Myeloproliferative Neoplasms: Results from the Nutrient Survey

Overexpression of Calreticulin Impairs Self-Renewal Capacity of Hematopoietic Stem Cells

JAK2 V617F Hematopoietic Stem Cells Exhibit a Blunted Response to Acute Inflammation

The MEK/ERK Inhibitor Trametinib Reduces Fibrosis in a Transduction-Transplantation Model of Mutated Calreticulin

Exaggerated Response To Toll-Like Receptor Agonist Contributes To Excessive TNF Production In Myeloproliferative Neoplasm

The CSF3R T618I Mutation Found In Chronic Neutrophilic Leukemia Removes An O-Linked Glycosylation Site and Increases Receptor Dimerization

CSF3R T618I Mouse Bone Marrow Transplant Model Of Neutrophilic Leukemia

TYK2-STAT1 Pathway Positively Regulates BCL2 Gene Expression in T-Cell Acute Lymphoblastic Leukemia

A Truncation Mutant of CSF3R, Identified As a Novel Driver in De Novo Myeloid Leukemia, Signals Through TNK2, and Is Responsive to Dasatinib.

Mutationally Activated TYK2 From T-ALL Specimens Exhibits Tranformative Capacity in Cell Lines and Primary Cell Models and T-Lineage Expansion in Mice

Jak2 V617F Induced TNF Resistance as a Mechanism of Clonal Expansion In Myeloproliferative Neoplasm

Effects of Plerixafor (AMD3100) In Combination with Tyrosine Kinase Inhibition In a Murine Model of CML.

Tumor Necrosis Factor-Alpha (TNF) Expression Is Elevated in Myelo-Proliferative Neoplasms (MPN) and Modulated by Inhibition of JAK2 V617F.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only